PDS Bio cuts 36% of workforce, removes COO Toutain; $842K charge

PDS Biotechnology Corp

Board approved Aug 6, 2026; RIF affects ~36% of workforce; notified Aug 21, 2026; Q3 completion.
Q3 2026 one-time charge ~$842K for severance and benefits; all cash expenditures.
COO Stephan Toutain removed without cause Aug 21, 2026; gets 12 months base salary plus COBRA.
RIF aligns operating expenses with strategic priorities focused on advancing PDS0301.

item 2.05 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Stephan Toutain

Chief Operating Officer

PDSB · PDS Biotechnology Corp

Effective: 2026-08-21
Filed: August 25, 2026, 4:08 PM ET

On August 21, 2026, the Company delivered a notice of termination without cause to Stephan Toutain and removed him from his position as the Company’s Chief Operating Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephan Toutain was removed as Chief Operating Officer at PDS Biotechnology Corp.

Action: removed
Role: Chief Operating Officer

Exact text from the filing

On August 21, 2026, the Company delivered a notice of termination without cause to Stephan Toutain and removed him from his position as the Company’s Chief Operating Officer.

View on SEC.gov

PDS Biotechnology Corp filing history →

Source: SEC EDGAR

accession 0001140361-26-034320

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.